Our Advisory Board assists in fundraising, public speaking and other PR activities to advance awareness of successful adult, cord blood and related stem three cell therapeutic options.
The Advisory Board serves in an advisory capacity to the Center's Director. Board members’ duties include fundraising, public speaking, and other public relations activities to advance public awareness of successful adult, cord blood and related stem three cell therapeutic options. The Board is required to meet at least four times each year and will be authorized to meet upon the call of the chairperson.
The Center’s director serves as an ex officio member of the Board. Advisory Board members may serve for only three consecutive terms and its members will serve without compensation. The bill provides for Board vacancies and appointments of successor members. The Governor will appoint the Board chairperson.
David Prentice, Ph.D.
Chair, Midwest Stem Cell Therapy Center Advisory Board
Vice President and Research Director, Charlotte Lozier Institute
Adjunct Professor of Molecular Genetics, John Paul II Institute
The Catholic University of America
Representative Dan Hawkins
Representative, State of Kansas
Chair, Health and Human Services
Vice Chair, Home and Community Based Services Oversight
Sunil Abhyankar, MD
Professor of Medicine
Director of Midwest Stem Cell Therapy Center
Medical Director - Pheresis and Cell Processing
Division of Hematologic Malignancies and Cellular Therapeutics
Lee Norman, MD
Secretary, Kansas Department of Health and Environment
Bassam Mattar, MD, FACP
Oncologist, Wichita, KS
Dr. Matthias Salathe, MD
Chair, Internal Medicine
School of Medicine
James L. Sherley, MD, Ph.D.
President and CEO
Senator Mike Thompson
Senator, State of Kansas
Senate Public Health and Welfare Committee
Mr. Jeff Wright
VP of Cancer Services
The University of Kansas Cancer Center
Frank Blecha, MD
College of Veterinary Medicine
University Distinguished Professor
Associate Dean of Research
Kansas State University
Scott Weir, Pharm D, Ph.D.
Professor of Clinical Pharmacology
Director, Institute for Advancing Medical Innovation, KUMC
Assoc Director, Translational Research, University of Kansas Cancer Center
Jennifer Robinson, Ph.D.
Chemical and Petroleum Engineering
University of Kansas
Ms. Ruth Colyer
Patient community representative
Greg Lakin, DO
Family Medicine Physician
Weijing Sun, MD, FACP
Division Director Medical Oncology
School of Medicine